Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ATEC | Common Stock | Sale | -$1.08M | -71.3K | -41.63% | $15.15 | 100K | Jun 12, 2023 | Direct | F2 |
holding | ATEC | Common Stock | 11.1M | Jun 12, 2023 | See footnote | F1, F2 |
Id | Content |
---|---|
F1 | Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein. |
F2 | Solely for purposes of Section 16 of the Exchange Act, Mr. Segal and L-5 may be deemed to be directors-by-deputization as a result of the service of Mr. Bakst on the board of directors of the Issuer. |